Stock Events

Stock Events

BVZ Holding

$792.04

4

-$47.26-5.63% Thursday 20:00

Statistics

Day High

-

Day Low

-

52W High

-

52W Low

-

Volume

-

Avg. Volume

-

Mkt Cap

0

P/E Ratio

42.13

Dividend Yield

-

Dividend

-

Upcoming

Dividend Payment

Dividend Payment

Dividends

0%Dividend Yield

Apr 26

$38.30

Apr 25

$21.99

Apr 24

$17.58

Apr 23

$16.84

Apr 22

$3.15

10Y Growth

10.55%

5Y Growth

N/A

3Y Growth

25.99%

1Y Growth

66.67%

Earnings

18MarExpected

Q2 2020

Q4 2020

Q2 2021

Q4 2021

Q2 2022

Q3 2023

Q4 2023

-44.45

-19.16

6.12

31.41

Expected EPS

N/A

Actual EPS

N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company based in Switzerland, directly competing with BVZ in various pharmaceutical and biotech segments.

Roche Holding AG is another Swiss multinational healthcare company that competes with BVZ in the development and marketing of pharmaceuticals and diagnostics.

Pfizer is a US-based global pharma company that competes with BVZ in the discovery, development, and manufacture of healthcare products including innovative medicines and vaccines.

Merck & Co., Inc. is a global healthcare company that competes with BVZ in providing healthcare solutions and innovations in various therapeutic areas.

Johnson & Johnson

Johnson & Johnson is a diversified healthcare giant that competes with BVZ across several segments, including pharmaceuticals, medical devices, and consumer health products.

GlaxoSmithKline is a British multinational pharmaceutical company that competes with BVZ in pharmaceuticals, vaccines, and consumer healthcare.

AbbVie is a global, research-driven biopharmaceutical company that competes with BVZ in developing and marketing advanced therapies.

Sanofi is a global biopharmaceutical company focused on human health, competing with BVZ in areas such as pharmaceuticals and vaccines.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company that competes with BVZ in the discovery, development, and delivery of innovative medicines.

AstraZeneca is a global, science-led biopharmaceutical business that competes with BVZ in developing and commercializing prescription medicines across several therapeutic areas.

About

Transportation

Railroads

BVZ Holding AG, through its subsidiaries, provides rail-related services. The company offers public railway transport, rolling stock, and maintenance services; tourist services; and automobile and freight transport services. It also engages in management, infrastructure, and real estate business. The company was founded in 1891 and is based in Brig, Switzerland.

Show more...

CEO

Fernando Lehner

Country

Switzerland

ISIN

CH0008207356

Listings

0 Comments

Share your thoughts

FAQ

What is BVZ Holding stock price today?▼

The current price of BVZHF is $792.04 USD — it has decreased by -5.63% in the past 24 hours. Watch BVZ Holding stock price performance more closely on the chart.

What is BVZ Holding stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange BVZ Holding stocks are traded under the ticker BVZHF.

What were BVZ Holding earnings last quarter?▼

BVZHF earnings for the last quarter are -7.14 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.

Does BVZ Holding pay dividends?▼

Yes, BVZHF dividends are paid annual. The last dividend per share was 3.15 USD. As of today, Dividend Yield (FWD)% is 0%.

In which sector is BVZ Holding located?▼

BVZ Holding operates in the Manufacturing sector.

When did BVZ Holding complete a stock split?▼

BVZ Holding has not had any recent stock splits.

Where is BVZ Holding headquartered?▼

BVZ Holding is headquartered in Brig-Glis, Switzerland.